4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-053236
EVP, Research & CSO sold 13,750 shares at $50.00 ($687,500)
- EVP, Research & CSO acquired 13,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…